search
Back to results

Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 (MoxiCov)

Primary Purpose

Oximetry, Covid19

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Digital oximeter monitoring
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Oximetry

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Over 18 years old
  • COVID 19 positive or suspected COVID19

Sites / Locations

  • Fundação Zerbini - Instituto do Coração (InCor)Recruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients monitored with oximeter

Arm Description

The first 45 patients will be monitored but the results will not be displayed. The second half of the patients the oximeter will have their monitoring data available online in the ward.

Outcomes

Primary Outcome Measures

Feasibility of the system: Determination of the number of valid versus not valid or missed measurements
Determination of the number of valid versus not valid or missed measurements of each participant.
Hypoxic burden
Time spent with SpO2< 93%, 90% and 85%
Hypoxic alarm
Number of times the oximeter record 3 consecutive measurements of SpO2<90%
Satisfaction of the nursing, medical team and patients with the implemented system
Measurement of NET PROMOTING SCORE (NPS). This score will show the satisfaction of the healthcare team with the device. This score have a minimum of 0 points and maximum of 32 points.

Secondary Outcome Measures

Time of SpO2<90%, SpO2<85% and SpO2<80%
Number of false alarms caused by malfunctions or bad oximeter positioning
Total hospital stay
Time of supplementary oxygen use
Mortality of participants

Full Information

First Posted
August 18, 2020
Last Updated
October 13, 2020
Sponsor
University of Sao Paulo General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04587921
Brief Title
Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19
Acronym
MoxiCov
Official Title
Feasibility and Impact of Remote Oximetry and Cardiac Frequency Monitoring in Patients Hospitalized and Isolated With Covid-19
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 22, 2020 (Actual)
Primary Completion Date
January 22, 2021 (Anticipated)
Study Completion Date
June 22, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of MoxiCov is to monitor the oximetry of patients admitted to the Covid nursery to provide a more detailed assistance expecting to reduce the amount of hypoxia in these patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oximetry, Covid19

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients monitored with oximeter
Arm Type
Experimental
Arm Description
The first 45 patients will be monitored but the results will not be displayed. The second half of the patients the oximeter will have their monitoring data available online in the ward.
Intervention Type
Device
Intervention Name(s)
Digital oximeter monitoring
Intervention Description
Digital oximeter and cardiac frequency monitoring.
Primary Outcome Measure Information:
Title
Feasibility of the system: Determination of the number of valid versus not valid or missed measurements
Description
Determination of the number of valid versus not valid or missed measurements of each participant.
Time Frame
6 months
Title
Hypoxic burden
Description
Time spent with SpO2< 93%, 90% and 85%
Time Frame
6 months
Title
Hypoxic alarm
Description
Number of times the oximeter record 3 consecutive measurements of SpO2<90%
Time Frame
6 months
Title
Satisfaction of the nursing, medical team and patients with the implemented system
Description
Measurement of NET PROMOTING SCORE (NPS). This score will show the satisfaction of the healthcare team with the device. This score have a minimum of 0 points and maximum of 32 points.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Time of SpO2<90%, SpO2<85% and SpO2<80%
Time Frame
6 months
Title
Number of false alarms caused by malfunctions or bad oximeter positioning
Time Frame
6 months
Title
Total hospital stay
Time Frame
6 months
Title
Time of supplementary oxygen use
Time Frame
6 months
Title
Mortality of participants
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Over 18 years old COVID 19 positive or suspected COVID19
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Diego Prieto, Msc
Phone
55 11 994385300
Email
diego.campos.prieto@gmail.com
Facility Information:
Facility Name
Fundação Zerbini - Instituto do Coração (InCor)
City
São Paulo
State/Province
SP
ZIP/Postal Code
054039000
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Diego Prieto, Msc
Phone
55 11 2661-5486
Email
diego.campos.prieto@gmail.com
First Name & Middle Initial & Last Name & Degree
Daniel Queiróz, PhD
Phone
55 11 2661-5486
Email
daniel.bc.queiroz@gmail.com
First Name & Middle Initial & Last Name & Degree
Geraldo Lorenzi, M.D. PhD
First Name & Middle Initial & Last Name & Degree
Luciano Drager, M.D. PhD
First Name & Middle Initial & Last Name & Degree
Pedro Genta, M.D PhD

12. IPD Sharing Statement

Learn more about this trial

Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19

We'll reach out to this number within 24 hrs